These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 9013349

  • 1. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
    Fornaciari G, Maccari S, Borgatti PP, Rustichelli R, Amelio N, Lattuada I, Plancher AC.
    J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349
    [Abstract] [Full Text] [Related]

  • 2. Mesalazine-induced bronchiolitis obliterans organizing pneumonia (BOOP) in a patient with ulcerative colitis and primary sclerosing cholangitis.
    Kevans D, Greene J, Galvin L, Morgan R, Murray FE.
    Inflamm Bowel Dis; 2011 Oct; 17(10):E137-8. PubMed ID: 21761513
    [No Abstract] [Full Text] [Related]

  • 3. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E.
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract] [Full Text] [Related]

  • 4. The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.
    Støa-Birketvedt G, Florholmen J.
    Aliment Pharmacol Ther; 1999 Mar; 13(3):357-61. PubMed ID: 10102969
    [Abstract] [Full Text] [Related]

  • 5. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU, Broomé U, Persson B.
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [Abstract] [Full Text] [Related]

  • 6. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP, Soyez C, Fignon A, Moraine C, Berger C, Autret E.
    Therapie; 1994 Jan; 49(5):443-5. PubMed ID: 7855761
    [Abstract] [Full Text] [Related]

  • 7. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M, Trapero-Marugán M, Guijarro M, López C, Moreno-Otero R, Gisbert JP.
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [Abstract] [Full Text] [Related]

  • 8. Nephrotic syndrome after treatment with 5-aminosalicylic acid.
    Novis BH, Korzets Z, Chen P, Bernheim J.
    Br Med J (Clin Res Ed); 1988 May 21; 296(6634):1442. PubMed ID: 3132281
    [No Abstract] [Full Text] [Related]

  • 9. Folliculitis and mesalamine.
    Lizasoain J, Rubio FA, Erdozain JC, Olveira A, Conde P.
    Am J Gastroenterol; 1996 Apr 21; 91(4):819-20. PubMed ID: 8677969
    [No Abstract] [Full Text] [Related]

  • 10. [Mesalazine].
    Engelhardt K, Mohr K.
    Dtsch Med Wochenschr; 1995 May 26; 120(21):769-70. PubMed ID: 7781502
    [No Abstract] [Full Text] [Related]

  • 11. Mesalazine induced exacerbation of ulcerative colitis.
    Kapur KC, Williams GT, Allison MC.
    Gut; 1995 Dec 26; 37(6):838-9. PubMed ID: 8537058
    [Abstract] [Full Text] [Related]

  • 12. Mesalamine-induced lung toxicity.
    Bitton A, Peppercorn MA, Hanrahan JP, Upton MP.
    Am J Gastroenterol; 1996 May 26; 91(5):1039-40. PubMed ID: 8633548
    [Abstract] [Full Text] [Related]

  • 13. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
    Pardi DS, Loftus EV, Kremers WK, Keach J, Lindor KD.
    Gastroenterology; 2003 Apr 26; 124(4):889-93. PubMed ID: 12671884
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [False melanuria in a female patient treated with 5-ASA for ulcerative colitis].
    Cuende JI, Gómez MT, García M, Pérez IJ.
    Med Clin (Barc); 1995 May 27; 104(20):798. PubMed ID: 7783478
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment and recurrence prevention ulcerative colitis].
    Schölmerich J.
    Internist (Berl); 1995 Dec 27; 36(12):1124-32. PubMed ID: 8567217
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Onerous concomitant complications of ulcerative colitis: a case report.
    Yüksel O, Arhan M, Köklü S, Oğuz P, Parlak E.
    Z Gastroenterol; 2007 May 27; 45(5):379-81. PubMed ID: 17503316
    [Abstract] [Full Text] [Related]

  • 20. 5-aminosalicylates in inflammatory bowel disease--the more the merrier?
    Forbes A.
    Eur J Gastroenterol Hepatol; 1995 Nov 27; 7(11):1017-9. PubMed ID: 8680898
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.